Skip to main content

All BHMG Oncology

Submissions from 2018 2018

Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial, Minesh Mehta

Brain Metastases in Lung Cancer With Targetable Mutations-Reply, Minesh Mehta

Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group, Minesh Mehta

Consolidative Whole-Brain Radiation Therapy Versus Autologous Stem Cell Transplant for Primary Central Nervous System Lymphoma: A Large Dose of Perspective and Perhaps a Lower Dose of Radiation Are in Order, Minesh Mehta

Control versus cognition: the changing paradigm of adjuvant therapy for resected brain metastasis, Minesh Mehta

Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases, Minesh Mehta

Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool, Minesh Mehta

Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539, Minesh Mehta

Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation, Minesh Mehta

Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancer, Minesh Mehta

Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02, Minesh Mehta

Prognostic and predictive factors in patients with brain metastases from solid tumors: A review of published nomograms, Minesh Mehta

Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation study, Minesh Mehta

Repeat reirradiation of the spinal cord: multi-national expert treatment recommendations, Minesh Mehta

Short delay in initiation of radiotherapy for patients with glioblastoma- effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database, Minesh Mehta

Temozolomide, sirolimus and chloroquine is a new therapeutic combination that synergizes to disrupt lysosomal function and cholesterol homeostasis in GBM cells, Minesh Mehta

The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists, Minesh Mehta

Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus, Minesh Mehta

What is the evidence for the clinical value of SBRT in cancer of the cervix?, Minesh Mehta

Postoperative Management of Resected Brain Metastases: When Can Radiotherapy Be Deferred?, Minesh Mehta and Rupesh Kotecha

How I treat the young patient with multiple myeloma, Claudia Paba Prada

Alcohol Consumption and Risk of Thyroid Cancer: A Population Based Case-Control Study in Connecticut, Robert Udelsman

Endocrine Surgery: A Hopkins Legacy, Robert Udelsman

Germline variants in DNA repair genes, diagnostic radiation and risk of thyroid cancer, Robert Udelsman

Parathyroid, Thyroid and Recurrent Laryngeal Nerve Anatomy in an Indian Rhinoceros (Rhinoceros unicornis), Robert Udelsman

EML4-ALK Rearrangement and Its Therapeutic Implications in Inflammatory Myofibroblastic Tumors, Fernando Vargas Madueno, Edwin Gould, Raul Valor, and Miguel Villalona Calero

Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung Cancer, Miguel Villalona Calero

Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC), Miguel Villalona Calero

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden, Miguel Villalona Calero and Zuanel Diaz

Preoperative Localization of Recurrence in the Thyroidectomy Bed Using a Radioactive Iodine(125) Seed, Geoffrey Young

Dosimetric Impact of Large Displacement of the Metal Port of the Tissue Expander in Intensity Modulated Proton Therapy, Jen Yu, Jaafar Bennouna, and Minesh Mehta

Submissions from 2017 2017

Predictors of Radiation Therapy-Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529, Andre Abitbol

Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee, Michael Chuong

The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings, Michael Chuong

A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients, Michael Chuong and Minesh Mehta

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper, John Paul Diaz and Jeffrey Boyd

Robotic assisted lobectomy for locally advanced lung cancer, Mark Dylewski

Integrative Oncology: A Paradigm Shift, Yoon-Hang "John" Kim

Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets, Murugesan Manoharan

Advance Care Planning: A Window to Palliative Care, Suleyki Medina

An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825, Minesh Mehta

A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas, Minesh Mehta

Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer, Minesh Mehta

Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients, Minesh Mehta

Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials, Minesh Mehta

Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA), Minesh Mehta

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525, Minesh Mehta

Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer, Minesh Mehta

Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation, Minesh Mehta

Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation, Minesh Mehta

State of the art: the evolving role of RT in combined modality therapy for GBM, Minesh Mehta

The Changing Role of Whole-Brain Radiotherapy: Demise or Time for Selective Usage?, Minesh Mehta

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria, Minesh Mehta

The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases, Minesh Mehta

The role of radiation in treating glioblastoma: here to stay, Minesh Mehta

Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer, Minesh Mehta and Michael Chuong

Changing Dogma and Decreased Collateral Damage in Breast Cancer Care, Jane Mendez

Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel : Part 1: Definitions, Assessments, Education, and Future Directions, Jane Mendez

Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema, Recommendations from an Expert Panel: Part 2: Preventive and Therapeutic Options, Jane Mendez

Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options, Yazmin Odia

Concurrent diagnosis of glioblastoma (GBM), neuromyelitis optica (NMO) spectrum disorder and Progressive Multifocal Leukoencephalopathy (PML): imaging, pathology, and clinical course. (P5.161), Yazmin Odia

Radiation Therapy for Liver Tumors: The State-of-the-art, Miguel Perez and Michael Chuong

BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors, Ashley Roque and Yazmin Odia

Submissions from 2016 2016

HPV-Associated Oropharyngeal Cancer: Changing Treatment Paradigm & Prognosis, Andre Abitbol

Postsurgical Depressive Symptoms and Proinflammatory Cytokine Elevations in Women Undergoing Primary Treatment for Breast Cancer, Robert Derhagopian

Postsurgical Depressive Symptoms and Proinflammatory Cytokine Elevations in Women Undergoing Primary Treatment for Breast Cancer, Robert Derhagopian

Measures of Appropriateness and Value for Breast Surgeons and Their Patients: The American Society of Breast Surgeons Choosing Wisely ® Initiative, Starr Mautner

An overview of modern proton therapy, Minesh Mehta

Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer, Minesh Mehta

Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review, Minesh Mehta

Clinical ramifications of "genomic staging" of low-grade gliomas, Minesh Mehta

International Medical Graduates in Radiation Oncology: Historical Trends and Comparison With Other Medical Specialties, Minesh Mehta

Low Levels of Acute Toxicity Associated With Proton Therapy for Low-Grade Glioma: A Proton Collaborative Group Study, Minesh Mehta

Reply to M.C. Chamberlain, Minesh Mehta

Stereotactic Radiosurgery for Treatment of Brain Metastases, Minesh Mehta

Gangliocytomas and Gangliogliomas: Review of Clinical, Pathologic and Genetic Features, Yazmin Odia

Widely metastatic atypical pituitary adenoma with mTOR pathway STK11(F298L) mutation treated with everolimus therapy, Yazmin Odia

Global Overview of Colorectal Cancer ― Past, Present and Future, Antonio Ucar

Veliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination Repair, Miguel Villalona Calero

Submissions from 2015 2015

Long-term psychological benefits of cognitive-behavioral stress management for women with breast cancer: 11-year follow-up of a randomized controlled trial, Robert Derhagopian

Randomized controlled trial of cognitive behavioral stress management in breast cancer: a brief report of effects on 5-year depressive symptoms, Robert Derhagopian

Brief Cognitive–Behavioral and Relaxation Training Interventions for Breast Cancer: A Randomized Controlled Trial, Robert Derhagopian, Gladys Giron, and Manuel A. Torres-Salichs

Submissions from 2014 2014

Predictors of radiotherapy-related GI toxicity from anal cancer DP-IMRT: Secondary analysis of RTOG 0529, Andre Abitbol

Sleep quality and fatigue after a stress management intervention for women with early-stage breast cancer in southern Florida, Robert Derhagopian

Submissions from 2012 2012

Accelerated partial breast irradiation is safe and effective using intensity-modulated radiation therapy in selected early-stage breast cancer, Alan Lewin, Robert Derhagopian, Andre Abitbol, D Jay Wieczorek, Vivek Mishra, and Lourdes Moreno

Submissions from 2011 2011

Cystic neutrophilic granulomatous mastitis: an underappreciated pattern strongly associated with gram-positive bacilli, Andrew Renshaw, Robert Derhagopian, and Edwin Gould

Submissions from 2007 2007

Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife, William Brown, Alan Lewin, and Andre Abitbol

Submissions from 2006 2006

Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision, Andrew Renshaw, Robert Derhagopian, Maria Pilar Martinez, and Edwin Gould

Submissions from 2005 2005

Phase II study of tolerance and efficacy of hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (taxol) and amifostine (ethyol) in head and neck squamous cell carcinomas: A-3 protocol, Andre Abitbol, Alan Lewin, and Michael Troner

Quality-of-life assessment after hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in inoperable and/or unresectable head and neck squamous cell carcinoma, Andre Abitbol, Alan Lewin, and Michael Troner

Submissions from 2004 2004

Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision, Andrew Renshaw, Robert Derhagopian, Dolores Tizol-Blanco, and Edwin Gould

Submissions from 2002 2002

Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol, Andre Abitbol, Alan Lewin, Michael Troner, and Maria-Amelia Rodrigues

Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma, Andrew Renshaw, Norberto Cartagena, Robert Derhagopian, and Edwin Gould

Submissions from 2001 2001

Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies, Andrew Renshaw, Norberto Cartagena, Randy Schenkman, Robert Derhagopian, and Edwin Gould

Submissions from 1996 1996

Management of stage I-B, II-A, and II-B carcinoma of the cervix with high-dose-rate brachytherapy: initial results of an institutional clinical trial, Andre Abitbol and Alan Lewin

Submissions from 1993 1993

Consensus guidelines for high dose rate remote brachytherapy in cervical, endometrial, and endobronchial tumors. Clinical Research Committee, American Endocurietherapy Society, Andre Abitbol

Submissions from 1992 1992

Stereotactic radiosurgery: dose-volume analysis of linear accelerator techniques, Christopher Serago, Alan Lewin, Andre Abitbol, Sergio Gonzalez-Arias, and Victor Marcial-Vega

Submissions from 1991 1991

Scattering effects on the dosimetry of iridium-192, Christopher Serago, Andre Abitbol, Alan Lewin, and Victor Marcial-Vega

Stereotactic target point verification of an X ray and CT localizer, Christopher Serago, Alan Lewin, Sergio Gonzalez-Arias, and Andre Abitbol

Improved linac dose distributions for radiosurgery with elliptically shaped fields, Christopher Serago, Alan Lewin, Sergio Gonzalez-Arias, Andre Abitbol, and Victor Marcial-Vega